objectives The recommended microscopy method by WHO to quantify malaria parasitaemia yields inaccurate results when individual leucocyte (WBC) counts deviate from 8000 leucocytes/ll. A method avoiding WBC count assumptions is the Lambar en e method (LAMBA). Thus, this study compared validity and reliability of the LAMBA and the WHO method.
Introduction
Light microscopy remains the gold standard for malaria diagnostics in clinical routine [1, 2] . Not only can microscopists detect parasites in a blood smear, they may also use a mathematical algorithm to quantify malaria parasitaemia. Knowledge of precise parasitaemia is important, as it can entail therapeutic consequences in clinical patient management, is used to monitor treatment success and plays a pivotal role in clinical research [3] [4] [5] [6] . The algorithms vary but most depend on counting parasites in a thick blood smear and putting them in relation to either the number of counted leucocytes or the number of investigated high power fields of the microscope [7] [8] [9] [10] [11] [12] . The former principle is applied in the recommended counting method of the World Health Organisation (WHO), which multiplies the ratio of counted parasites per leucocyte in the blood smear by the absolute leucocyte (WBC) counts from haematological analysis [7] [8] [9] . When WBC determination is not feasible, the use of an approximate factor of 8000 leucocytes/ll is recommended. Studies from South America, Africa and SouthEast Asia have shown that this can yield considerably inaccurate results given that individual WBC counts often significantly deviate from the assumed value of 8000/ll [13] [14] [15] . This can lead to relevant under or overestimations of actual parasitaemia [13] [14] [15] . Such inaccuracies seem plausible as an assumed WBC factor of 8000/ll can neither account for between-subject variability nor for within-subject variability of WBC counts.
The Lambar en e method (LAMBA) is based on the principle of counting the number of parasites in high power microscope fields [10, 11] . It was first described in 1988 by Kremsner et al. [16] in Brazil and later named after the town in Gabon where the Centre de Recherches M edicales de Lambar en e (CERMEL) is located [17] . There it has been used in hundreds of clinical studies. LAMBA determines the average number of parasites per field which are subsequently multiplied with a microscope-specific factor [10] . This factor holds information on the number of fields needed to investigate 1 ll blood of a thick blood smear. LAMBA is a quick and straightforward method that does not require parallel counting of parasites and leucocytes [10, 11] . Further, there is no evidence indicating that its performance may be affected by patient populations with extremely low or high WBC counts.
Accurate measurements of parasitaemia are important for academic studies and for patient management [3] [4] [5] [6] . Due to the scarce availability of routine haematology analysis in resource-limited malaria-endemic settings the importance of microscope-only methods is highlighted; such that can accurately quantify malaria parasitaemia in the absence of information on individual WBCs. Thus, this study investigated the validity and reliability of LAMBA and compared it with the WHO method relying on an assumed WBC factor of 8000/ll. In view of the method's inaccuracy for populations with low and high WBC counts, method performance was modelled over the whole WBC range of study participants. Also, we assessed the potential of LAMBA and the WHO method to correctly detect parasites in a thick smear when recommended microscopic counting limits are applied.
Methods

Study population
The study population participated in a study on malaria [18] , conducted at CERMEL and ethical clearance was granted by the local independent ethics committee (Reference number: CEI-CERMEL: 009/2015). Thick blood smears were included in the study if matching results of haematological analysis were available for the respective participant. Results from haematological analysis were deemed adequately matched if they stemmed from the same time point at which thick smears were prepared.
Determination of parasitaemia in light microscopy
Calculation algorithms and counting limits for the Lambar en e (LAMBA) and WHO methods (aWHO and sWHO) used in this study are given in Tables 1-3 . It is within the range of these counting limits that a microscopist needs to detect at least 1 parasite to determine parasite positivity in a thick smear and subsequently quantify parasitaemia with a respective calculation algorithm. For the WHO method, WBCs were determined by ABX Pentra 60 (Horiba Medical, Montpellier) analyser from a venous blood sample -referred to as 'accurate WHO method' (aWHO) in this paper. The method using an assumed factor of 8000 leucocytes/ll is referred to as 'simple WHO method' (sWHO). All microscopists performing parasitological analyses in this study had passed dedicated exams for malaria diagnostics according to WHO standards.
Slides were read as follows: during microscopy of an individual thick smear, the reader recorded (i) the number of counted parasites, (ii) the number of counted fields and (iii) the number of counted leucocytes. Reading continued to the point when all method requirements for ending the slide reading procedure were reached (Tables 2 and 3 ). Subsequently, on the basis of these results, parasitaemias according to aWHO, sWHO and LAMBA were computed using respective algorithms (Table 1) . Thus, one read yielded three parasitological results, one each by aWHO, by sWHO and by LAMBA. Results obtained by this method allowed to investigate the true between-method differences in parasitaemia. Thus intra-rater and inter-rater variability of malaria slide microscopy were adjusted for and two major sources of potential bias for the determination of method reliability and between-method measurement errors eliminated [19] . Consequently, there are no discordant test results in our data set with regards to the presence of Plasmodium spp in a blood smear; slides were either concordantly negative or concordantly positive. As only positive samples can produce quantifiable parasitaemias, the analysis population only contained positive smears. Readers were blinded to the parasitological results of the original study and microscopic analysis was performed within a month of initial sample preparation [18] .
Malaria slide preparation and staining
Each thick smear that was included in this study had been prepared with 10 ll of blood which was evenly spread with a plastic pipette tip across a standardised rectangular area of 1.8 cm 2 . After smear preparation and drying, the slides were stained with Giemsa 4% for 60 min. Then a squeeze bottle was used to clean the smear of remaining Giemsa. Thick smears were excluded from analysis if their quality was not deemed adequate.
Determination of microscope factor
The microscope factor (MF) was determined on the basis of the following concepts:
Microscopic field: The circular area seen when looking through a microscope. The size of the area is p/4 9 d 2 . d: Field-of-view diameter or simply the diameter of the microscopic field. This is typically the field number (given in mm) of the ocular divided by the magnification of the objective. Detailed information on this can be found in the manufacturer's manual of the respective microscope. Microscopes used for reading thick blood smears usually use a 109 ocular and 1009 objective magnifications, and the field diameter is around 0.18 mm. A: The area of the thick blood smear. In this study, a rectangular thick blood smear of 1 9 1.8 cm, or 1.8 cm 2 was performed. V: The volume of blood used for the thick blood smear; 10 ll in this study. MF: The microscope factor, or the number of microscopic fields that cover 1 ll of blood on a thick blood smear. On an evenly spread smear, a volume of V/A blood is found per lm 2 area. A microscopic field therefore covers a volume of p/4 9 d 2 9 V/A. The inverse of this is the number of microscopic fields that cover 1 ll of blood. Here, this quantity is referred to as 'microscope factor (MF)'.
The average number of parasites per field multiplied with fields per ll blood will give the number of parasites per ll of blood. parasites per ll blood ¼ average parasites per high power field Â MF A calculated example and an alternative microscope factor determination method are presented in the Appendix S1.
Statistical analysis
Statistical operations were conducted with STATA/SE 15.1 (StataCorp, USA). For all models, the aWHO was regarded as the gold standard for microscopic parasitaemia. Parasitaemia (expressed as parasites/ll blood) was log-transformed and the following analyses were performed. Table 1 Calculation algorithms [7] [8] [9] [10] Lambar en e method (number of counted parasites/number of investigated HPFs) 9 microscope factor WHO method † (number of counted parasites/number of counted leukocytes) 9 absolute leucocyte count HPF, high power field. †For both simple and accurate WHO methods. Comparison of validity. Validity is the extent to which a method accurately measures the true value of a variable of interest. The COSMIN panel defined it as 'the degree to which an instrument truly measures the construct it purports to measure' [20] . To determine method validity difference plots with 95% confidence intervals (CIs) were created of log(parasitaemia accurate WHO method ) À log(parasitaemia alternative method ) [21] . These plots were computed in analogy to classic Bland-Altman plots, such that differences are demonstrated over the whole range of measurements [22] . However, as the models focus on differences rather than on agreement no limits of agreement were constructed. As log-transformed data were used for calculations, the anti-log of a difference results in a ratio (i.e. parasitaemia accurate WHO method /parasitaemia alternative method ) allowing to see the deviation of the respective method (LAMBA and sWHO) from aWHO in percent [23] .
Comparison of reliability. Reliability is the extent to which a method yields the same result upon repeated measurement. The COSMIN panel defined it as 'the degree to which measurement is free from measurement error' [20] . To determine the reliability of respective methods intraclass correlation coefficients (ICCs) were calculated for LAMBA and sWHO, respectively with aWHO. Microscopy methods were treated as fixed effects and absolute agreement was selected when computing ICCs.
Subpopulations of varying average WBCs. To assess and compare performances of LAMBA and sWHO in malaria patients with low and high WBC counts the study population was divided into four equally sized quartiles according to their WBC-values. They are referred to as 'First WBC quartile' to 'Fourth WBC quartile' in the manuscript for better comprehensibility. Further, a linear regression model was computed to show the respective method's deviation from aWHO in percent as a linear function of individual WBC count.
Subpopulations of varying parasitaemias. Method performance was also assessed for thick smears of low (1-100 parasites/ll), moderate (101-10 000 parasites/ll) and high parasitaemias (>10 000 parasites/ll).
Potential of respective methods to detect parasites in thick smear. To assess the question whether LAMBA or the WHO method is more favourable to detect parasites in a thick smear the following steps were performed: For each microscopic reading the two ratios of number of counted parasites/number of investigated HPFs and number of counted parasites/number of counted leukocytes were computed. Next, the average numbers of parasites per 100 HPFs and per 500 leucocytes were modelled. These values constitute the routine counting limits for low parasitaemias of LAMBA and the WHO method, respectively (Tables 2 and 3 ) within which a microscopist needs to detect at least one parasite to determine parasite positivity. Subsequently, the proportion of readings was ascertained for which the average number of parasites per 100 HPFs and per 500 leucocytes, respectively was at least 1. Numbers smaller than one were judged to reflect parasitaemia undetectable by a trained microscopist.
Results
Study population
Of 1760 thick smears from study participants who had given informed consent we included 787 (45%) malariapositive thick smears with matching WBC counts in the analysis ( Figure 1 ).
Performance of LAMBA and sWHO Table 4 and Figure 2 show differences between aWHO and alternative methods. Figures 3 and 4 show the differences between aWHO and other methods over the whole range of WBC-measurements. For populations with low WBC counts both LAMBA and sWHO overestimated parasitaemia by +25% (+22 to +28) and +41% (+40 to +43) ('First WBC quartile'), and +15% (+11 to +18) and +19% (+19 to +20) ('Second WBC quartile'), respectively. This trend was reversed when WBCs approximated 8000/ll ('Third WBC quartile'), with +1.2% (À3.2 to +5.3) for LAMBA and À2.4% (À3.5 to À1.3) for sWHO. For populations with high WBC counts ('Fourth WBC quartile') both LAMBA and sWHO underestimated parasitaemia by À18% (À23 to À13) and À39% (À42 to À36), respectively.
Intraclass correlation coefficients and corresponding 95% CIs were nearly always >90%; with the exception of 91% (87.8 to 93.1) for LAMBA and 86% (81.7 to 89.5) for sWHO in the 'First WBC quartile', and 89% (86 to 91.9) for LAMBA in the 'Second WBC quartile' ( Table 4) .
Equations of linear regression models were y = À0.00608x (95% CI À0.00693 to À0.00524) + 47.8 (95% CI 40.9 to 54.7) for LAMBA and y = À0.0125x (95% CI À0.01253 to À0.01247) + 100.1 (95% CI 99.8 to 100.3) for sWHO, where slopes constitute the measurement deviation from gold standard parasitaemia in percent per one unit increase in WBC count (Figure 4) . The four hypothetical examples in Table 5 demonstrate how each method can lead to true or false classifications of malaria patients who consequently may be subjected to suboptimal antimalarial treatment.
No method detected all parasitaemias when applying strict counting limits as given in Tables 2 and 3 . The reason for this is that for some thick smears microscopists read more fields and/or leucocytes than are minimally required. However, one can see that the proportion of detected parasitaemias was higher by LAMBA than by the WHO method (Table 6 ). This gap was especially high for low parasitaemias, manifesting in a difference in the proportion of detected parasitaemias between the two methods of 12.4% (P < 0.0001). Interestingly when 1000 leucocytes were applied as counting limit the potential to detect parasite positivity was equal for LAMBA and the WHO methods (P = 1).
Validity analyses show that low parasitaemias determined by LAMBA were closer to the gold standard than sWHO (P = 0.0156). For moderate and high parasitaemias there were no significant differences (P = 0.21 and P = 0.58, respectively; Table 7 and Figure 5) 
Discussion
Validity can be likened to the capability of hitting the bull's eye, and reliability to how narrowly hits are clustered on the dart board [24] . This study investigated the validity and reliability of two common microscopy methods for the detection and quantification of malaria parasitaemia [7] [8] [9] [10] [11] . This constitutes valuable knowledge as microscopy is still the gold standard of malaria diagnosis in clinical routine and moreover used to assess disease severity and treatment response [1] [2] [3] 25] . However, haematology analysers, which are needed to obtain individual WBC counts for the determination of the precise parasitaemia, are often unavailable in malaria-endemic settings. This highlights the necessity of reliable and valid microscope-only methods to determine parasitaemia in the absence of information on individual WBC counts. Difference plots showed that deviations of LAMBA and sWHO rise with WBC count deviations from an assumed factor of 8000 leucocytes/ll blood, as previously seen in studies from South-East Asia, South America and Africa [13] [14] [15] . However, the systematic measurement bias was consistently lower for LAMBA than for sWHO. This gap was apparent in all difference plots and became larger the more actual WBCs deviated from 8000/ll. Linear regression models (Figure 4) showed a negative linear relationship between deviation from gold standard and individual WBCs. For LAMBA this is a deviation of À0.00608% from the gold standard per one unit increase in WBC (i.e. per 'one additional leucocyte/ll'). For sWHO this is a À0.0125% deviation from the gold standard per one unit increase in WBC, which is more than twice as high as for LAMBA (P < 0.001).
Concurrently, the variation in results pertaining to LAMBA was by trend higher than for sWHO. This is demonstrated by a wider spread of data points in difference plots, and generally wider confidence intervals for deviations and comparatively lower ICCs. This slightly poorer reliability of LAMBA may be explained by two reasons: First, the thickness of the blood smear may not have been constant across the smear due to difficulties in evenly spreading 10 ll of blood on a 1.8 cm 2 area. Second, the similarity of calculation algorithms of parasitaemia between sWHO and aWHO may entail a high degree of collinearity, as only values for WBC counts are different, while the ratio of number of counted parasites/number of counted leukocytes stays constant. This can explain the resulting high values of ICCs and the generally narrow 95% CIs for sWHO. Nevertheless, most ICCs of LAMBA and sWHO were above 90%, which is defined as excellent [26] . Notably, although ICCs of sWHO were generally more favourable, it performed worse than LAMBA for populations with a low WBC count ('First WBC quartile') with 86% (81.7 to 89.5) vs. 91% (87.8 to 93.1), respectively.
Four hypothetical scenarios on how malaria patients may be truly or falsely classified as suffering from 'uncomplicated malaria' or 'severe malaria' owing to systematic measurement bias of non-gold standard quantification methods of parasitaemia (Table 5) demonstrate that performance of LAMBA was still sufficient to correctly classify disease severity of patients, whereas sWHO would produce misleading evidence for clinicians that could potentially impair adequate patient management. This study demonstrates that LAMBA detected parasites more often than the WHO method with a counting limit of 500 leucocytes. This superiority was especially pronounced for low parasitaemias (97.2% vs. 84.8%; P < 0.0001). Interestingly, when doubling the WHOrecommended counting limit to 1000 leucocytes, no differences between the two methods were detectable (P = 1; Table 6 ). These findings are in line with a study by Joanny et al. [11] demonstrating that LAMBA has a slightly lower limit of detection than the WHO method (62 parasites/ll vs. 88 parasites/ll, respectively). This more favourable performance of LAMBA in detecting low parasitaemias entails a variety of scenarios in which implementation of LAMBA could be potentially beneficial: First, in clinical routine, by facilitating to correctly detect a higher proportion of malaria patients; second, in public health campaigns targeted at malaria control or at malaria elimination, by detecting a higher proportion of infected individuals with low parasitaemias. It is these individuals that constitute an important parasite reservoir which is of great significance for transmission of the infection to mosquitoes [27] . Third, in clinical studies expecting populations with low malaria parasitaemias, such as malaria vaccination trials or trials on antimalarial chemotherapy, where reduction of parasitaemia is often an important outcome. Alternatively, the recommended counting limit of WHO could be extended (e.g. to 1000 leucocytes), Supplementary information for examples † (1-4): (1) Hyperparasitaemia: Plasmodium falciparum parasitaemia >10% (%500 000/ll); (2a) Jaundice: Plasma or serum bilirubin >50 lmol/l (3 mg/dl) with a parasite count >100 000/ll; (2b) Plasmodium knowlesi, hyperparasitaemia: parasite density >100 000/ll; (3) Plasmodium knowlesi, jaundice and parasite density >20 000/ll; (4) Severe malarial anaemia: Haemoglobin concentration ≤5 g/dl or a haematocrit of ≤15% in children <12 years of age (<7 g/dl and <20%, respectively, in adults) with a parasite count >10 000/ll. †Examples constitute criteria of severe malaria requiring adaptation of patient management according to WHO guidelines [1, 25] .
thereby also increasing the proportion of detected malaria parasites. However, as we saw the sWHO's measures of validity and reliability are less favourable for low parasitaemias ( Figure 5 and Table 7 ). Further, there is a risk that implementing a standard counting limit of 1000 leucocytes may be too time-consuming in the often stressful reality of clinical routine in tropical settings (especially during seasons of high transmission). Time constraints may urge microscopists to estimate the average number of leucocytes per field instead of precisely counting them, thereby opening the doors to potential bias and impairing the quality of accurate measurements. Although 'reading time' was not a recorded outcome for this study, counting fields is quicker and less tedious than counting numerous leucocytes per field. Therefore, LAMBA may lead to robust results more quickly than the WHO method, thereby being potentially more useful in meeting the needs of busy clinical or research units. Lastly, studies that do not routinely evaluate WBC counts may benefit from LAMBA, as a single microscopic sample prepared from finger prick blood suffices for appropriate method performance. It is worth mentioning that LAMBA is in principle not restricted to application in blood samples. In theory, other media may also be used for quantification of the respective unit of interest (e.g. another microorganism). Therefore, under certain circumstances laboratory studies may advantageously use LAMBA when their microscopic samples do not contain leucocytes, for example in an in-vitro culture of Plasmodium spp, when the sample value of erythrocytes/ll cannot be determined.
Conclusion
Both LAMBA and sWHO are straightforward and reliable tools to determine Plasmodium parasitaemia. However, their validity decreases the more patients' WBC Counting limits: †Until 100 high power fields; ‡until 500 leucocytes; §until 1000 leucocytes. counts deviate from an average value of 8000/ll. The slope with which validity decreases is twice more favourable for LAMBA than for sWHO. LAMBA is also better able to detect and accurately quantify low-level parasitaemias. Thus, resource-limited settings without access to haematology analysers may choose this method for routine determination of parasitaemia. Depending on the research question, research centres may find the application of LAMBA beneficial as well.
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